AC Immune (ACIU) Total Current Liabilities (2015 - 2026)

AC Immune (ACIU) has 12 years of Total Current Liabilities data on file, last reported at $117.8 billion in Q1 2026.

• On a quarterly basis, Total Current Liabilities rose 106617.05% year-over-year to $117.8 billion in Q1 2026; TTM through Mar 2026 was $117.8 billion, a 106617.05% increase from a year earlier, with the FY2025 full-year figure at $114.2 billion, up 99120.86% from the prior year.
• Total Current Liabilities for Q1 2026 stood at $117.8 billion, down from $118.5 billion in the prior quarter.
• Over the last five years, Total Current Liabilities for ACIU reached as high as $118.5 billion in Q4 2025 and fell as low as $11.6 million in Q1 2023.
• Historically, Total Current Liabilities has averaged $16.3 billion across 5 years, with a median of $115.1 million in 2024.
• Across the five-year window, Total Current Liabilities tumbled 99.95% in 2022 and jumped 128323.97% in 2023, its largest moves.
• Year by year, Total Current Liabilities stood at $11.9 million in 2022, then jumped by 128323.97% to $15.3 billion in 2023, then plunged by 99.25% to $115.1 million in 2024, then jumped by 102826.14% to $118.5 billion in 2025, then dropped by 0.57% to $117.8 billion in 2026.
• Per Business Quant data, the three most recent Total Current Liabilities figures were $117.8 billion in Q1 2026, $118.5 billion in Q4 2025, and $122.9 million in Q3 2025.